Board Committees

For nearly 29 years, Jacque Millard was the Vice President and Chief Investment Officer for Intermountain Healthcare where she led the investment department to invest more than $15 billion across multiple portfolios. Today, she is the Audit Committee Chair for PACS Group Inc. and Board Chair for FJI.

She is the former Board Chair for Youthlinc and has served on multiple endowment and foundation boards or investment committees, including Avent Health, Virginia Piper Trust, Westminster College, and Deseret Mutual Benefit Association. She is also a member of the National Association of Corporate Directors (NACD) and has completed the Director Professionalism certification.

Jacque’s mission, to enhance investment performance and improve governance, is embodied in her professional and personal life. She brings her skill sets to foundations, family offices, and private companies to make a positive impact on their mission.  She is personally committed to seeking places where she can make a significant impact in the board room.

Taylor Leavitt is Managing Partner and CEO of Leavitt Equity Partners. He received an MBA from the UCLA Anderson School of Business and graduated magna cum laude from Utah State University with degrees in finance, economics, and international business. Taylor brings nearly 20 years of healthcare and finance experience and has been responsible for managing and executing the overall mission of LEP, its investment activities, and subsequent performance.

Before Leavitt Equity Partners, Taylor launched and led Leavitt Partners’ (the consulting firm) Equity Practice which advised both private equity and hedge funds on healthcare investment opportunities and industry dynamics. Prior to joining Leavitt Partners, Taylor worked for ZARS Pharma, a venture capital funded pharmaceutical company, engaged in corporate acquisitions, licensing and business development operations. While at ZARS, he identified and executed strategic corporate transactions on a global basis, including mergers and acquisitions and IP and technology licenses.

Taylor enjoys spending time with his family, including supporting his four daughters’ dance activities.

Evelyn Dilsaver is a prominent leader in both the public and nonprofit sectors, with experience in marketing, strategy, and business development. She spent nearly two decades in the audit and finance function as Controller for First Nationwide Bank, as well as Controller for Charles Schwab. Following, she went on to become Chief Financial Officer and Chief Administrative Officer for U.S. Trust, and later served as President and CEO of Charles Schwab Investment Management, where she grew assets to over $200 billion and generated over $1 billion in company revenue.

Today, Evelyn leverages her expertise and leadership in a variety of corporate and nonprofit Board roles, including Tempur Sealy (TPX), Health Equity (HQY), QuidelOrtho (QDEl), Bailard REIT, and the global consulting firm Proviti, in addition to PACS. She previously served as Board Chair for The Commonwealth Club, Board Chair for the Blue Shield of California Foundation, and Co-Chair of the Women Corporate Directors Advisory Board, as well as a Board member of Blue Shield of California, Long Drugs, Tamalpais, Bancorp, Aeropostale, High Mark Funds and the National Association of Corporate Directors, Northern California Chapter.

Taylor Leavitt is Managing Partner and CEO of Leavitt Equity Partners. He received an MBA from the UCLA Anderson School of Business and graduated magna cum laude from Utah State University with degrees in finance, economics, and international business. Taylor brings nearly 20 years of healthcare and finance experience and has been responsible for managing and executing the overall mission of LEP, its investment activities, and subsequent performance.

Before Leavitt Equity Partners, Taylor launched and led Leavitt Partners’ (the consulting firm) Equity Practice which advised both private equity and hedge funds on healthcare investment opportunities and industry dynamics. Prior to joining Leavitt Partners, Taylor worked for ZARS Pharma, a venture capital funded pharmaceutical company, engaged in corporate acquisitions, licensing and business development operations. While at ZARS, he identified and executed strategic corporate transactions on a global basis, including mergers and acquisitions and IP and technology licenses.

Taylor enjoys spending time with his family, including supporting his four daughters’ dance activities.

Patrick H. Conway, MD, MSc, is the Chief Executive Officer of Optum, the health services business of UnitedHealth Group. He previously served as CEO of Care Solutions at Optum, as President and CEO of Blue Cross and Blue Shield of North Carolina, and as Deputy Administrator for Innovation and Quality at the Centers for Medicare and Medicaid Services, where he also served as the agency’s Chief Medical Officer, Director of the Center for Medicare and Medicaid Innovation (CMMI), and Acting Administrator. Dr. Conway is a practicing pediatric hospitalist, a member of the National Academy of Medicine, and a recipient of the President’s Senior Executive Distinguished Service Award. He holds an M.D. with High Honors from Baylor College of Medicine, a Master of Science in Clinical Epidemiology from the University of Pennsylvania, and a bachelor’s degree from Texas A&M University.

Evelyn Dilsaver is a prominent leader in both the public and nonprofit sectors, with experience in marketing, strategy, and business development. She spent nearly two decades in the audit and finance function as Controller for First Nationwide Bank, as well as Controller for Charles Schwab. Following, she went on to become Chief Financial Officer and Chief Administrative Officer for U.S. Trust, and later served as President and CEO of Charles Schwab Investment Management, where she grew assets to over $200 billion and generated over $1 billion in company revenue.

Today, Evelyn leverages her expertise and leadership in a variety of corporate and nonprofit Board roles, including Tempur Sealy (TPX), Health Equity (HQY), QuidelOrtho (QDEl), Bailard REIT, and the global consulting firm Proviti, in addition to PACS. She previously served as Board Chair for The Commonwealth Club, Board Chair for the Blue Shield of California Foundation, and Co-Chair of the Women Corporate Directors Advisory Board, as well as a Board member of Blue Shield of California, Long Drugs, Tamalpais, Bancorp, Aeropostale, High Mark Funds and the National Association of Corporate Directors, Northern California Chapter.

For nearly 29 years, Jacque Millard was the Vice President and Chief Investment Officer for Intermountain Healthcare where she led the investment department to invest more than $15 billion across multiple portfolios. Today, she is the Audit Committee Chair for PACS Group Inc. and Board Chair for FJI.

She is the former Board Chair for Youthlinc and has served on multiple endowment and foundation boards or investment committees, including Avent Health, Virginia Piper Trust, Westminster College, and Deseret Mutual Benefit Association. She is also a member of the National Association of Corporate Directors (NACD) and has completed the Director Professionalism certification.

Jacque’s mission, to enhance investment performance and improve governance, is embodied in her professional and personal life. She brings her skill sets to foundations, family offices, and private companies to make a positive impact on their mission.  She is personally committed to seeking places where she can make a significant impact in the board room.

Patrick H. Conway, MD, MSc, is the Chief Executive Officer of Optum, the health services business of UnitedHealth Group. He previously served as CEO of Care Solutions at Optum, as President and CEO of Blue Cross and Blue Shield of North Carolina, and as Deputy Administrator for Innovation and Quality at the Centers for Medicare and Medicaid Services, where he also served as the agency’s Chief Medical Officer, Director of the Center for Medicare and Medicaid Innovation (CMMI), and Acting Administrator. Dr. Conway is a practicing pediatric hospitalist, a member of the National Academy of Medicine, and a recipient of the President’s Senior Executive Distinguished Service Award. He holds an M.D. with High Honors from Baylor College of Medicine, a Master of Science in Clinical Epidemiology from the University of Pennsylvania, and a bachelor’s degree from Texas A&M University.

Taylor Leavitt is Managing Partner and CEO of Leavitt Equity Partners. He received an MBA from the UCLA Anderson School of Business and graduated magna cum laude from Utah State University with degrees in finance, economics, and international business. Taylor brings nearly 20 years of healthcare and finance experience and has been responsible for managing and executing the overall mission of LEP, its investment activities, and subsequent performance.

Before Leavitt Equity Partners, Taylor launched and led Leavitt Partners’ (the consulting firm) Equity Practice which advised both private equity and hedge funds on healthcare investment opportunities and industry dynamics. Prior to joining Leavitt Partners, Taylor worked for ZARS Pharma, a venture capital funded pharmaceutical company, engaged in corporate acquisitions, licensing and business development operations. While at ZARS, he identified and executed strategic corporate transactions on a global basis, including mergers and acquisitions and IP and technology licenses.

Taylor enjoys spending time with his family, including supporting his four daughters’ dance activities.